In these scenarios, tumor cells often exhibit CCR7 positivity alongside increased extracellular matrix levels of CCL21, supporting enhanced migratory capacity mediated via the PI3K/Akt and mTOR signaling pathways (33, 38, 39). This evidence concerns the gene CCL21 and neoplasm.